Integra LifeSciences Holdings Corp. (IART)

13.88 +0.73 (+5.55%) USD  |  NASDAQ  |  Jan 08, 16:00
13.88 0.00 (0.00%) After-Hours: 20:00
More

Integra LifeSciences Holdings Research and Development Expense (Quarterly): 20.42M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for IART.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Masimo Corp. 30.50M
Merit Medical Systems, Inc. 23.97M
Clearpoint Neuro, Inc. 3.452M
Tandem Diabetes Care, Inc. 47.88M
iRhythm Technologies, Inc. 21.03M